Overcoming challenges in the diagnosis and treatment of parasitic infectious diseases in migrants

References

• World Health Organization. [cited 2019 oct 16]. Available from: https://www.who.int/migrants/en/
   Google Scholar
• European Centre for Disease Prevention and Control. Public health guidance on screening and vaccination for infectious diseases in newly arrived migrants within the EU/EEA. Stockholm: ECDC; 2018. Stockholm, Nov 2018. ISBN 978-92-9498-280-3. Catalogue number TQ-04-18-919-EN-N. doi: 10.2900/154411.
   Google Scholar
• Castelli F. Drivers of migration: why do people move? J Travel Med. 2018 Jul 1;25(1):1-7.
   Google Scholar
• Leder K, Tong S, Weld L, et al. GeoSentinel surveillance network. Illness in travelers visiting friends and relatives: a review of the geosentinel surveillance network. Clin Infect Dis. 2006 Nov 1;43(9):1185–1193.
   PubMed Web of Science ®Google Scholar
• Norman FF, López-Polín A, Salvador F, et al. +REDIVI study group. Imported malaria in Spain (2009-2016): results from the +REDIVI collaborative network. Malar J. 2017 Oct 10;16(1):407.
   PubMedGoogle Scholar
• Heywood AE, López-Vélez R. Reducing infectious disease inequities among migrants. J Travel Med. 2019 Feb 1;26(2)pii: tay131.
   PubMed Web of Science ®Google Scholar
• Hjern A, Stubbe Ostergaard L, Norrendam ML. Health examinations of child migrants in Europe: screening or assessment of healthcare needs? BMJ Paediatr Open. 2019. 1. 3(1):e000411.
   PubMedGoogle Scholar
• Basile L, Jansa JM, Carlier Y, et al. Working group on chagas disease. Chagas disease in European countries: the challenge of a surveillance system. Euro Surveill. 2011 Sep 15;16(37):8.
   Google Scholar
• WHO | World malaria report. WHO. World Health Organization; 2018 2019 [cited 2019 Nov 3]. Available from: https://www.who.int/malaria/publications/country-profiles/profile_idn_en.pdf?ua=1
   Google Scholar
• Rossati A, Bargiacchi O, Kroumova V, et al. Climate, environment and transmission of malaria. Infez Med. 2016;24(2):93–104.
   PubMedGoogle Scholar
• European Centre for Disease Prevention and Control. Multiple reports of locally-acquired malaria infections in the EU. Stockholm: ECDC; 2017. [20 Sep].
   Google Scholar
• Hertig E. Distribution of Anopheles vectors and potential malaria transmission stability in Europe and the mediterranean area under future climate change. Parasites Vectors. 2019;12(1):1–9.
   PubMedGoogle Scholar
• Santa-Olalla Peralta P, Vazquez-Torres MC, Latorre-Fandos E, et al. First autochthonous malaria case due to plasmodium vivax since eradication, Spain, October. Euro Surveill. 2010;15(41):19684. 2010.
   PubMedGoogle Scholar
• de Zulueta J, Ramsdale CD, Coluzzi M. Receptivity to malaria in Europe. Bull World Health Organ. 1975;52(1):109–111.
   PubMed Web of Science ®Google Scholar
• Toty C, Barré H, Le Goff G, et al. Malaria risk in Corsica, former hot spot of malaria in France. Malar J. 2010 Aug 12;9(231):231.
   PubMedGoogle Scholar
• Zammarchi L, Di Lauria N, Bartalesi F, et al. Cryptic severe plasmodium falciparum malaria in a Moroccan man living in Tuscany, Italy, August 2018. Euro Surveill. 2018 Oct;23(41) pii: 1800527.
   Google Scholar
• Doolan DL, Dobaño C, Baird JK. Acquired immunity to Malaria. Clin Microbiol Rev. 2009;22(1):13–36.
   PubMed Web of Science ®Google Scholar
• Fradejas I, Rubio JM, Martín-Díaz A, et al. Prevalence of submicroscopic malaria infection in immigrants living in Spain. Malar J. 2019;18(1):1–9.
   PubMedGoogle Scholar
• Pousibet-Puerto J, Cabezas-Fernández MT, Lozano-Serrano AB, et al. Submicroscopic malaria in migrants from sub-saharan Africa, Spain. Emerg Infect Dis. 2019;25(2):349–352.
   PubMed Web of Science ®Google Scholar
• Dolo H, Coulibaly YI, Dembele B, et al. Filariasis attenuates anemia and proinflammatory responses associated with clinical malaria: a matched prospective study in children and young adults. PLoS Negl Trop Dis. 2012;6(11):e1890.
   PubMed Web of Science ®Google Scholar
• Driedger M, Mayhew A, Welch V, et al. Accessibility and acceptability of infectious disease interventions among migrants in the EU/EEA: a CERQual systematic review. Int J Environ Res Public Health. 2018;15(11):2329.
   PubMed Web of Science ®Google Scholar
• Rosano A, Dauvrin M, Buttigieg SC, et al. Migrant’s access to preventive health services in five EU countries. BMC Health Serv Res. 2017 Aug 23;17(1):588.
   PubMedGoogle Scholar
• Monge-Maillo B, Norman F, Pérez-molina JA, et al. Plasmodium falciparum in asymptomatic immigrants from Sub-Saharan Africa. Emerg Infect Dis. 2012;18(2):356–357.
   PubMed Web of Science ®Google Scholar
• D’Ortenzio E, Godineau N, Fontanet A, et al. Prolonged plasmodium falciparum infection in immigrants, Paris. Emerg Infect Dis. 2008;14(2):323–326.
   PubMed Web of Science ®Google Scholar
• Monge-Maillo B, López-Vélez R. Is screening for malaria necessary among asymptomatic refugees and immigrants coming from endemic countries? Expert Rev Anti Infect Ther. 2011;9(5):521–524.
   PubMed Web of Science ®Google Scholar
• Wångdahl A, Wyss K, Saduddin D, et al. Severity of plasmodium falciparum and non-falciparum malaria in travelers and migrants: a nationwide observational study over 2 Decades in Sweden. J Infect Dis. 2019;220(8):1335–1345.
   PubMed Web of Science ®Google Scholar
• Charpentier E, Benichou E, Pagès A, et al. Performance evaluation of different strategies based on microscopy techniques, rapid diagnostic test and molecular loop-mediated isothermal amplification assay for the diagnosis of imported malaria. Clin Microbiol Infect. 2020;26(1):115-121.
   PubMed Web of Science ®Google Scholar
• Matisz CE, Naidu P, Shokoples SE, et al. Post-arrival screening for malaria in asymptomatic refugees using real-time PCR. Am J Trop Med Hyg. 2011;84(1):161–165.
   PubMed Web of Science ®Google Scholar
• Hofmann N, Mwingira F, Shekalaghe S, et al. Ultra-sensitive detection of plasmodium falciparum by amplification of multi-copy subtelomeric targets. PLOS Med. 2015;12(3):e1001788.
   PubMed Web of Science ®Google Scholar
• Imwong M, Hanchana S, Malleret B, et al. High-throughput ultrasensitive molecular techniques for quantifying low-density malaria parasitemias. J Clin Microbiol. 2014;52(9):3303–3309.
   PubMed Web of Science ®Google Scholar
• Mohon AN, Getie S, Jahan N, et al. Ultrasensitive loop mediated isothermal amplification (US-LAMP) to detect malaria for elimination. Malar J. 2019;18(1):350.
   PubMed Web of Science ®Google Scholar
• Hofmann NE, Gruenberg M, Nate E, et al. Assessment of ultra-sensitive malaria diagnosis versus standard molecular diagnostics for malaria elimination: an in-depth molecular community cross-sectional study. Lancet Infect Dis. 2018;18(10):1108–1116.
   PubMed Web of Science ®Google Scholar
• WHO. Guidelines For the treatment of malaria; 2015 [cited 2019 Nov 13]. Available from: https://www.who.int/malaria/publications/atoz/9789241549127/en/
   Google Scholar
• Collinet-Adler S, Stauffer WM, Boulware DR, et al. Financial implications of refugee malaria: the impact of pre-departure presumptive treatment with anti-malarial drugs. Am J Trop Med Hyg. 2007;77(3):458–463.
   PubMed Web of Science ®Google Scholar
• Howes RE, Battle KE, Satyagraha AW, et al. G6PD Deficiency: global distribution, genetic variants and primaquine therapy. Adv Parasitol. 2013; 81:133–201.
   PubMed Web of Science ®Google Scholar
• von Seidlein L, Auburn S, Espino F, et al. Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report. Malar J. 2013;12:112.
   PubMed Web of Science ®Google Scholar
• Lacerda MVG, Llanos-Cuentas A, Krudsood S, et al. Single-dose tafenoquine to prevent relapse of plasmodium vivax Malaria. N Engl J Med. 2019;380(3):215–228.
   PubMed Web of Science ®Google Scholar
• Rosiglitazone Adjunctive Therapy for Severe Malaria in Children (ROSI). Available from: [ cited2019Nov12]. https://clinicaltrials.gov/ct2/show/NCT02694874
   Google Scholar
• Haldar K, Bhattacharjee S, Safeukui I. Drug resistance in plasmodium. Nat Rev Microbiol. 2018;16(3):156–170.
   PubMed Web of Science ®Google Scholar
• Wang J, Xu C, Liao FL, et al. A temporizing solution to “artemisinin resistance”. N Engl J Med. 2019;380(22):2087–2089.
   PubMed Web of Science ®Google Scholar
• RTS,S Clinical Trials Partnership. Efficacy and safety of RTS,S/AS01. malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet. 2015;386(9988):31–45.
   PubMed Web of Science ®Google Scholar
• Organización Panamericana de la Salud. Guía para el diagnóstico y el tratamiento de la enfermedad de Chagas. Washington, D.C.: OPS; 2018.
   Google Scholar
• Bern C. Chagas´ Disease. N Engl J Med. 2015;373:456.
   PubMed Web of Science ®Google Scholar
• Manne-Goehler J, Umeh CA, Montgomery SP, et al. Estimating the burden of chagas disease in the United States. PLoS Negl Trop Dis. 2016;10(11):e0005033.
   PubMed Web of Science ®Google Scholar
• Requena-Méndez A, Aldasoro E, de Lazzari E, et al. Prevalence of Chagas disease in Latin-American migrants living in Europe: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2015;9(2):e0003540.
   PubMed Web of Science ®Google Scholar
• Pérez-Molina JA, López-Polín A, Treviño B, et al. +Redivi study group. 6-year review of +Redivi: a prospective registry of imported infectious diseases in Spain. J Travel Med. 2017;24(5):1–7.
   PubMed Web of Science ®Google Scholar
• Manne-Goehler J, Reich MR, Wirtz VJ. Access to care for Chagas disease in the United States: a health systems analysis. Am J Trop Med Hyg. 2015;93(1):108–113.
   PubMed Web of Science ®Google Scholar
• Navarro M, Monge-Maillo B, Flores-Chavez MD, et al. Hunting hidden parasites: trypansoma cruzi. Lancet. 2017;390:724–726.
   PubMed Web of Science ®Google Scholar
• Norman FF, López-Vélez R. Chagas disease: comments on the 2018 PAHO Guidelines for diagnosis and management. J Travel Med. 2019;26(7):pii: taz060.
   PubMed Web of Science ®Google Scholar
• Monge-Maillo B, López-Vélez R. Challenges in the management of Chagas disease in Latin-American migrants in Europe. Clin Microbiol Infect. 2017;23(5):290–295.
   PubMed Web of Science ®Google Scholar
• Requena-Méndez A, Bussion S, Aldasoro E, et al. Cost-effectiveness of Chagas disease screening in Latin American migrants at primary health-care centres in Europe: a Markov model analysis. Lancet Glob Health. 2017;5(4):e439–e447.
   PubMed Web of Science ®Google Scholar
• Sicuri E, Muñoz J, Pinazo MJ, et al. Economic evaluation of Chagas disease screening of pregnant Latin American women and of their infants in a non endemic area. Acta Trop. 2011;118(2):110–117.
   PubMed Web of Science ®Google Scholar
• Carlier Y, Altcheh J, Angheben A, et al. Congenital Chagas disease: updated recommendations for prevention, diagnosis, treatment, and follow-up of newborns and siblings, girls, women of childbearing age, and pregnant women. PLoS Negl Trop Dis. 2019;13(10):e0007694.
   PubMed Web of Science ®Google Scholar
• Romay-Barja M, Boquete T, Martinez O, et al. Chagas screening and treatment among Bolivians living in Madrid, Spain: the need for an official protocol. PLoS One. 2019;14(3):e0213577.
   PubMed Web of Science ®Google Scholar
• Riera C, Verges M, Iniesta L, et al. Identification of a Western blot pattern for the specific diagnosis of Trypanosoma cruzi infection in human sera. Am J Trop Med Hyg. 2012;86(3):412–416.
   PubMed Web of Science ®Google Scholar
• Angheben A, Buonfrate D, Cruciani M, et al. Rapid immunochromatographic tests for the diagnosis of chronic Chagas disease in at-risk populations: A systematic review and meta-analysis. PLoS Negl Trop Dis. 2019;13(5):e0007271.
   PubMed Web of Science ®Google Scholar
• Egüez KE, Alonso-Padilla J, Terán C, et al. Rapid diagnostic tests duo as alternative to conventional serological assays for conclusive Chagas disease diagnosis. PLoS Negl Trop Dis. 2017;11(4):e0005501.
   PubMed Web of Science ®Google Scholar
• Picado A, Cruz I, Redard-Jacot M, et al. The burden of congenital Chagas disease and implementation of molecular diagnostic tools in Latin America. BMJ Glob Health. 2018;3:e001069.
   PubMed Web of Science ®Google Scholar
• Besuschio SA, Llano Murcia M, Benatar AF, et al. Analytical sensitivity and specificity of a loop-mediated isothermal amplification (LAMP) kit prototype for detection of Trypanosoma cruzi DNA in human blood samples. PLoS Negl Trop Dis. 2017;11(7):e0005779.
   PubMed Web of Science ®Google Scholar
• Nunes MCP, Badano LP, Marin-Neto JA, et al. Multimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI). Eur Heart J Cardiovasc Imaging. 2018;19(4):459–460n.
   PubMed Web of Science ®Google Scholar
• Georg I, Hasslocher-Moreno AM, Xavier SS, et al. Evolution of anti-Trypanosoma cruzi antibody production in patients with chronic Chagas disease: correlation between antibody titers and development of cardiac disease severity. PLoS Negl Trop Dis. 2017;11(7):e0005796.
   PubMed Web of Science ®Google Scholar
• Passos LSA, Magalhães LMD, Soares RP, et al. Specific activation of CD4- CD8- double-negative T cells by Trypanosoma cruzi-derived glycolipids induces a proinflammatory profile associated with cardiomyopathy in Chagas patients. Clin Exp Immunol. 2017;190(1):122–132.
   PubMed Web of Science ®Google Scholar
• Cardoso CS, Ribeiro ALP, Oliveira CDL, et al. Beneficial effects of benznidazole in Chagas disease: NIH SaMi-Trop cohort study. PLoS Negl Trop Dis. 2018;12(11):e0006814.
   PubMed Web of Science ®Google Scholar
• Morillo CA, Marin-Neto JA, Avezum A, et al. Randomized trial of benznidazole for chronic Chagas’ cardiomyopathy. N Engl J Med. 2015;373(14):1295–1306.
   PubMed Web of Science ®Google Scholar
• Pinazo MJ, Miranda B, Rodriguez-Villar C, et al. Recommendations for management of Chagas disease in organ and hematopoietic tissue transplantation programs in nonendemic areas. Transplant Rev (Orlando). 2011;25:91–101.
   PubMedGoogle Scholar
• Fiorelli AI, Santos RH, Oliveira JL Jr, et al. Heart transplantation in 107 cases of Chagas’ disease. Transplant Proc. 2011;43:220–224.
   PubMed Web of Science ®Google Scholar
• Crespillo-Andújar C, Chamorro-Tojeiro S, Norman FF, et al. Toxicity of nifurtimox as second-line treatment after benznidazole intolerance in patients with chronic Chagas disease: when available options fail. Clin Microbiol Infect. 2018;24:1344.e1–1344.e4.
   PubMed Web of Science ®Google Scholar
• Molina I, Gómez I Prat J, Salvador F. Randomized trial of posaconazole and benznidazole for chronic Chagas’ disease. N Engl J Med. 2014;370:1899–1908.
   PubMed Web of Science ®Google Scholar
• Torrico F, Gascon J, Ortiz L, et al. Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial. Lancet Inf Dis. 2018;18(4):419–430.
   PubMed Web of Science ®Google Scholar
• Morillo CA, Waskin H, Sosa-Estani S, et al. Benznidazole and posaconazole in eliminating parasites in asymptomatic T. cruzi carriers: the STOP-CHAGAS trial. J Am Coll Cardiol. 2017;69:939–947.
   PubMed Web of Science ®Google Scholar
• Oral Fexinidazole Dosing Regimens for the Treatment of Adults With Chronic Indeterminate Chagas Disease (FEXI12). [cited 2019 Jul 24]. Available from: https://clinicaltrials.gov/ct2/show/NCT03587766?cond=fexinidazole&rank=3
   Google Scholar
• Evaluation of Different Benznidazole Regimens for the Treatment of Chronic Chagas Disease. (MULTIBENZ). [cited 2019 Dec 12]. Available from: https://clinicaltrials.gov/ct2/show/NCT03191162
   Google Scholar
• Prospective Study of Pediatric Nifurtimox formulation for Chagas Disease (CHICO). [cited 2019 Dec 12]. Available from: https://clinicaltrials.gov/ct2/show/NCT02625974
   Google Scholar
• Roquero I, Cantizani J, Cotillo I, et al. Novel chemical starting points for drug discovery in leishmaniasis and Chagas disease. Int J Parasitol Drugs Drug Resist. 2019;10:58–68.
   PubMed Web of Science ®Google Scholar
• Quijia Quezada C, Azevedo CS, Charneau S, et al. Advances in nanocarriers as drug delivery systems in Chagas disease. Int J Nanomedicine. 2019;14:6407–6424.
   PubMed Web of Science ®Google Scholar
• Arrúa EC, Seremeta KP, Bedogni GR, et al. Nanocarriers for effective delivery of benznidazole and nifurtimox in the treatment of Chagas disease: A review. Acta Trop. 2019;198:105080.
   PubMed Web of Science ®Google Scholar
• Rios LE, Vázquez-Chagoyán JC, Pacheco AO, et al. Immunity and vaccine development efforts against trypanosoma cruzi. Acta Trop. 2019;200:105168.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Control of the Leishmaniases. World health organ tech rep ser xii-xiii. 2010. p. 1–186. World Health Organization.
   Google Scholar
• WHO. Surveillance of leishmaniasis in the WHO European Region, 2016. Weekly Epidemiological Rec. 2018;93:521–540.
   Google Scholar
• Du R, Hotez PJ, Al-Salem WS, et al. Old world cutaneous leishmaniasis and refugee crises in the middle East and North Africa. PLoS Negl Trop Dis. 2016;10:e0004545.
   PubMed Web of Science ®Google Scholar
• El Hajj R, El Hajj H, Khalifeh I. Fatal visceral leishmaniasis caused by leishmania infantum, Lebanon. Emerg Infect Dis. 2018;24:906–907.
   PubMed Web of Science ®Google Scholar
• Norman FF, Pérez de Ayala A, Pérez-Molina JA, et al. Neglected tropical diseases outside the tropics. PLoS Negl Trop Dis. 2010;4:e762.
   PubMed Web of Science ®Google Scholar
• Söbirk SK, Inghammar M, Collin M, et al. Imported leishmaniasis in Sweden 1993-2016. Epidemiol Infect. 2018;146:1267–1274.
   PubMed Web of Science ®Google Scholar
• Arce A, Estirado A, Ordobas M, et al. Re-emergence of leishmaniasis in Spain: community outbreak in Madrid, Spain, 2009 to 2012. Euro Surveill. 2013;18:20546.
   PubMedGoogle Scholar
• Monge-Maillo B, Norman FF, Cruz I, et al. Visceral leishmaniasis and HIV coinfection in the Mediterranean region. PLoS Negl Trop Dis. 2014;8:e3021.
   PubMed Web of Science ®Google Scholar
• Bangert M, Flores-Chávez MD, Llanes-Acevedo IP, et al. Validation of rK39 immunochromatographic test and direct agglutination test for the diagnosis of Mediterranean visceral leishmaniasis in Spain. PLoS Negl Trop Dis. 2018;12:e0006277.
   PubMed Web of Science ®Google Scholar
• Mollett G, Bremer Hinckel BC, Bhattacharyya T, et al. Detection of Immunoglobulin G1 against rK39 improves monitoring of treatment outcomes in visceral leishmaniasis. Clin Infect Dis. 2019;69:1130–1135.
   PubMed Web of Science ®Google Scholar
• Aronson NE. Addressing a clinical challenge: guidelines for the diagnosis and treatment of leishmaniasis. BMC Med. 2017;15 (1):76.
   Web of Science ®Google Scholar
• Van der Auwera G, Bart A, Chicharro C, et al. Comparison of leishmania typing results obtained from 16 European clinical laboratories in 2014. Euro Surveill. 2016;21(49): pii: 30418.
   PubMedGoogle Scholar
• Adams ER, Schoone G, Versteeg I, et al. Development and evaluation of a novel loop-mediated isothermal amplification assay for diagnosis of cutaneous and visceral leishmaniasis. J Clin Microbiol. 2018;56:7.
   Web of Science ®Google Scholar
• Aronson N, Herwaldt BL, Libman M, et al. Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the infectious diseases society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Am J Trop Med Hygiene. 2017;96:24–45.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Manual on Case Management and Surveillance of the Leishmaniases in the WHO European Region, 2017, WHO Regional office for Europe; [cited 2019 Dec 19]. Available from: http://www.euro.who.int/en/publications/abstracts/manual-on-case-management-and-surveillance-of-the-leishmaniases-in-the-who-european-region-2017
   Google Scholar
• A Study of a New Leishmania Vaccine Candidate ChAd63-KH (Leish2a). [cited 2019 oct 30]. Available from: https://clinicaltrials.gov/ct2/show/NCT02894008?cond=leishmania&draw=2&rank=4
   Google Scholar
• Saidin S, Othman N, Noordin R. Update on laboratory diagnosis of amoebiasis. Eur J Clin Microbiol Infect Dis. 2019;38(1):15–38.
   PubMed Web of Science ®Google Scholar
• Van Den Broucke S, Verschueren J, Van Esbroeck M, et al. Clinical and microscopic predictors of entamoeba histolytica intestinal infection in travelers and migrants diagnosed with entamoeba histolytica/dispar infection. PLoS Negl Trop Dis. 2018;12(10):e0006892–e0006892.
   PubMed Web of Science ®Google Scholar
• Hung -C-C, Ji -D-D, Sun H-Y, et al. Increased risk for Entamoeba histolytica infection and invasive amebiasis in HIV seropositive men who have sex with men in Taiwan. PLoS Negl Trop Dis. 2008;2(2):e175–e175.
   PubMed Web of Science ®Google Scholar
• Shirley D-AT, Farr L, Watanabe K, et al. A review of the global burden, new diagnostics, and current therapeutics for amebiasis. Open Forum Infect Dis. 2018;5(7):ofy161–ofy161.
   PubMed Web of Science ®Google Scholar
• Kantor M, Abrantes A, Estevez A, et al. Entamoeba histolytica: updates in clinical manifestation, pathogenesis, and vaccine development. Can J Gastroenterol Hepatol. 2018;4601420.
   Google Scholar
• Monge-Maillo B, López-Vélez R, Norman FF, et al. Screening of imported infectious diseases among asymptomatic sub-Saharan African and Latin American immigrants: a public health challenge. Am J Trop Med Hyg. 2015;92(4):848–856.
   PubMed Web of Science ®Google Scholar
• Gutiérrez-Cisneros MJ, Cogollos R, López-Vélez R, et al. Application of real-time PCR for the differentiation of Entamoeba histolytica and E. dispar in cyst-positive faecal samples from 130 immigrants living in Spain. Ann Trop Med Parasitol. 2010;104(2):145–149.
   PubMed Web of Science ®Google Scholar
• Gonzales MLM, Dans LF, Sio-Aguilar J. Antiamoebic drugs for treating amoebic colitis. Cochrane Database Syst Rev. 2019;1(1):CD006085.
   PubMedGoogle Scholar
• Shirley D-A, Moonah S. Fulminant amebic colitis after corticosteroid therapy: a systematic review. PLoS Negl Trop Dis. 2016;10(7):e0004879.
   PubMed Web of Science ®Google Scholar
• Asundi A, Beliavsky A, Liu XJ, et al. Prevalence of strongyloidiasis and schistosomiasis among migrants: a systematic review and meta-analysis. Lancet Glob Health. 2019;7(4):e419.
   Web of Science ®Google Scholar
• McCarthy AE, Weld LH, Barnett ED, et al. GeoSentinel surveillance network. Spectrum of illness in international migrants seen at geosentinel clinics in 1997-2009, part 2: migrants resettled internationally and evaluated for specific health concerns. Clin Infect Dis. 2013;56(7):925–933.
   PubMed Web of Science ®Google Scholar
• Salvador F, Treviño B, Chamorro-Tojeiro S, et al. on behalf the +REDIVI collaborative network. Imported strongyloidiasis: data from 1245 cases registered in the +REDIVI Spanish collaborative network (2009-2017). PLoS Negl Trop Dis. 2019;13(5):e0007399.
   PubMed Web of Science ®Google Scholar
• Nordheim E, Olafsson Storrø M, Natvik AK, et al. Donor-derived strongyloidiasis after organ transplantation in Norway. Transpl Infect Dis. 2019;21(1):e13008.
   PubMed Web of Science ®Google Scholar
• Kim JH, Kim DS, Yoon YK, et al. Donor-derived strongyloidiasis infection in solid organ transplant recipients: a review and pooled analysis. Transplant Proc. 2016;48(7):2442–2449.
   PubMed Web of Science ®Google Scholar
• Schär F, Trostdorf U, Giardina F, et al. Strongyloides stercoralis: global distribution and risk factors. PLoS Negl Trop Dis. 2013;7(7):e2288.
   PubMed Web of Science ®Google Scholar
• Vasquez-Rios G, Pineda-Reyes R, Pineda-Reyes J, et al. Strongyloides stercoralis hyperinfection syndrome: a deeper understanding of a neglected disease. J Parasit Dis. 2019;43(2):167–175.
   PubMedGoogle Scholar
• Requena-Mendez A, Chiodini P, Bisoffi Z, et al. The laboratory diagnosis and follow up of strongyloidiasis: a systematic review. PLoS Negl Trop Dis. 2013;7(1):e2002.
   PubMed Web of Science ®Google Scholar
• Krolewiecki A, Nutman TB. Strongyloidiasis: a neglected tropical disease. Infect Dis Clin North Am. 2019;33(1):135–151.
   PubMed Web of Science ®Google Scholar
• Llewellyn S, Inpankaew T, Nery SV, et al. Application of a multiplex quantitative PCR to assess prevalence and intensity of intestinal parasite infections in a controlled clinical trial. PLoS Negl Trop Dis. 2016;10(1):e0004380.
   PubMed Web of Science ®Google Scholar
• Henriquez-Camacho C, Gotuzzo E, Echevarria J, et al. Ivermectin versus albendazole or thiabendazole for strongyloides stercoralis infection. Cochrane Database Syst Rev. 2016;18(1):CD007745.
   Google Scholar
• Buonfrate D, Salas-Coronas J, Muñoz J, et al. Multiple-dose versus single-dose ivermectin for strongyloides stercoralis infection (strong treat 1 to 4): a multicentre, open-label, phase 3, randomised controlled superiority trial. Lancet Inf Dis. 2019;19(11):1181–1190.
   PubMed Web of Science ®Google Scholar
• Martinez-Perez A, Roure Díez S, Belhassen-Garcia M, et al. Soil-Transmitted Helminths’ Study Group of the Spanish Society of Tropical Medicine and International Health (SEMTSI). Management of severe strongyloidiasis attended at reference centers in Spain. PLoS Negl Trop Dis. 2018;12(2):e0006272.
   PubMedGoogle Scholar
• Albonico M, Becker SL, Odermatt P, et al. StrongNet working group. StrongNet: an international network to improve diagnostics and access to treatment for strongyloidiasis control. PLoS Negl Trop Dis. 2016;10(9):e0004898.
   PubMed Web of Science ®Google Scholar
• Fusco DN, Downs JA, Satlin MJ, et al. Non-oral treatment with ivermectin for disseminated strongyloidiasis. Am J Trop Med Hyg. 2010;83(4):879–883.
   PubMed Web of Science ®Google Scholar
• Barrett J, Broderick C, Soulsby H, et al. Subcutaneous ivermectin use in the treatment of severe strongyloides stercoralis infection: two case reports and a discussion of the literature. J Antimicrob Chemother. 2016;71(1):220–225.
   PubMed Web of Science ®Google Scholar
• Prichard RK, Geary TG. Perspectives on the utility of moxidectin for the control of parasitic nematodes in the face of developing anthelmintic resistance. Int J Parasitol Drugs Drug Resist. 2019;10:69–83.
   PubMed Web of Science ®Google Scholar
• Efficacy, safety, and PK of ascending dosages of moxidectin versus ivermectin against strongyloidiasis stercoralis (strongMoxy); [cited 2019 oct 30]. Available from: https://clinicaltrials.gov/ct2/show/NCT04056325
   Google Scholar
• Yeung SHM, Mourad O, Klowak M, et al. Implementation and evaluation of a quality and safety tool for ambulatory strongyloidiasis patients at high risk of adverse outcome. Trop Dis Travel Med Vaccines. 2019;5:3.
   PubMedGoogle Scholar
• Anselmi M, Buonfrate D, Guevara Espinoza A, et al. Mass administration of ivermectin for the elimination of onchocerciasis significantly reduced and maintained low the prevalence of strongyloides stercoralis in Esmeraldas, Ecuador. PLoS Negl Trop Dis. 2015;9(11):e0004150.
   PubMed Web of Science ®Google Scholar
• Barda B, Albonico M, Buonfrate D, et al. Side benefits of mass drug administration for lymphatic filariasis on strongyloides stercoralis prevalence on Pemba Island, Tanzania. Am J Trop Med Hyg. 2017;97(3):681–683.
   PubMed Web of Science ®Google Scholar
• Levenhagen MA, Conte H, Costa-Cruz JM. Current progress toward vaccine and passive immunization approaches for strongyloides spp. Immunol Lett. 2016;180:17–23.
   PubMed Web of Science ®Google Scholar
• Monge-Maillo B, Jiménez BC, Pérez-Molina JA, et al. Imported infectious diseases in mobile populations, Spain. Emerg Infect Dis. 2009;15(11):1745–1752.
   PubMed Web of Science ®Google Scholar
• Salas-Coronas J, Cabezas-Fernández MT, Lozano-Serrano AB, et al. Newly arrived African migrants to Spain: epidemiology and burden of disease. Am J Trop Med Hyg. 2018;98:319–325.
   PubMed Web of Science ®Google Scholar
• Monge-Maillo B, Norman FF, Pérez-Molina JA, et al. Travelers visiting friends and relatives (VFR) and imported infectious disease: travelers, immigrants or both? A comparative analysis. Travel Med Infect Dis. 2014;12:88–94.
   PubMed Web of Science ®Google Scholar
• Ramaiah KD. Population migration: implications for lymphatic filariasis elimination programmes. PLoS Negl Trop Dis. 2013;7:e2079.
   PubMed Web of Science ®Google Scholar
• Jones RT. Non-endemic cases of lymphatic filariasis. Trop Med Int Health. 2014;19:1377–1383.
   PubMed Web of Science ®Google Scholar
• Abdel-Shafi IR, Shoieb EY, Attia SS, et al. Molecular identification and phylogenetic analysis of Wuchereria bancrofti from human blood samples in Egypt. Parasitol Res. 2017;116(3):963–970.
   PubMed Web of Science ®Google Scholar
• Puente S, Ramirez-Olivencia G, Lago M, et al. Dermatological manifestations in onchocerciasis: A retrospective study of 400 imported cases. Enferm Infecc Microbiol Clin. 2018;36:633–639.
   PubMed Web of Science ®Google Scholar
• Antinori S, Parravicini C, Galimberti L, et al. Is imported onchocerciasis a truly rare entity? Case report and review of the literature. Travel Med Infect Dis. 2017;16:11–17.
   PubMed Web of Science ®Google Scholar
• Showler AJ, Nutman TB. Imported onchocerciasis in migrants and travelers. Curr Opin Infect Dis. 2018;31:393–398.
   PubMed Web of Science ®Google Scholar
• Churchill DR, Morris C, Fakoya A, et al. Clinical and laboratory features of patients with loiasis (Loa loa filariasis) in the U.K. J Infect. 1996;33:103.
   PubMed Web of Science ®Google Scholar
• Klion AD, Massougbodji A, Sadeler BC, et al. Loiasis in endemic and nonendemic populations: immunologically mediated differences in clinical presentation. J Infect Dis. 1991;163:1318e25.
   Web of Science ®Google Scholar
• Gantois N, Rapp C, Gautret P, et al. Imported loiasis in France: a retrospective analysis of 47 cases. Travel Med Infect Dis. 2013;11:366–373.
   PubMed Web of Science ®Google Scholar
• Gobbi F, Postiglione C, Angheben A, et al. Imported loiasis in Italy: an analysis of 100 cases. Travel Med Infect Dis. 2014;12:713–717.
   PubMed Web of Science ®Google Scholar
• Saito M, Armstrong M, Boadi S, et al. Clinical features of imported loiasis: a case series from the hospital for tropical diseases, London. Am J Trop Med Hyg. 2015;93:607–611.
   PubMed Web of Science ®Google Scholar
• Jha R, Gangwar M, Chahar D, et al. Humans from Wuchereria bancrofti endemic area elicit substantial immune response to proteins of the filarial parasite Brugia malayi and its endosymbiont Wolbachia. Parasit Vectors. 2017;10(1):40.
   PubMedGoogle Scholar
• World Health Organization. [ cited 2019Nov12]. Available from: https://www.who.int/schistosomiasis/disease/en/
   Google Scholar
• Salas-Coronas J, Vázquez-Villegas J, A B L-S, et al. Severe complications of imported schistosomiasis, Spain: A retrospective observational study. Trav Med Infect Dis. 2019;101508.
   Google Scholar
• Colley DG, Bustinduy AL, Secor WC, et al. Human schistosomiasis. Lancet. 2014;383:2253–2264.
   PubMed Web of Science ®Google Scholar
• Ramalli L, Mulero S, Noël H, et al. Persistence of schistosomal transmission linked to the Cavu River in southern Corsica since 2013. Euro Surveill. 2018. 23(4). pii=18-00017.
   PubMedGoogle Scholar
• Panagiotopoulos TakisScreening for infectious diseases in newly arrived migrants in Europe: the context matters. Euro Surveill. 23(28): pii=1800283. 2018.
   PubMedGoogle Scholar
• Agbata EN, Morton RL, Bisoffi Z, et al. Effectiveness of screening and treatment approaches for schistosomiasis and strongyloidiasis in newly-arrived Migrants from Endemic Countries in the EU/EEA: a systematic review. Int J Environ Res Public Health. 2018;16(1):11. pii: E11.
   PubMed Web of Science ®Google Scholar
• Beltrame A, Guerriero M, Angheben A, et al. Accuracy of parasitological and immunological tests for the screening of human schistosomiasis in immigrants and refugees from African countries: an approach with latent class analysis. PLoS Negl Trop Dis. 2017;11(6):e0005593.
   PubMed Web of Science ®Google Scholar
• Guegan H, Fillaux J, Charpentier E, et al. Real-time PCR for diagnosis of imported schistosomiasis. PLoS Negl Trop Dis. 2019;13(9):e0007711.
   PubMed Web of Science ®Google Scholar
• Zammarchi L, Bonati M, Strohmeyer M, et al. COHEMI project study group. Screening, diagnosis and management of human cysticercosis and Taenia solium taeniasis: technical recommendations by the COHEMI project study group. Trop Med Int Health. 2017;22(7):881–894.
   PubMed Web of Science ®Google Scholar
• Zammarchi L, Angheben A, Fantoni T, et al. Screening for neurocysticercosis in internationally adopted children: yield, cost and performance of serological tests, Italy, 2001 to 2016. Euro Surveill. 2018;23(40). pii: 1700709.
   Google Scholar
• Danso-Appiah A, Olliaro PL, Donegan S, et al. Drugs for treating Schistosoma mansoni infection. Cochrane Database Syst Rev. 2013(2):CD000528.
   PubMed Web of Science ®Google Scholar
• Kramer CV, Zhang F, Sinclair D, et al. Drugs for treating urinary schistosomiasis. Cochrane Database Syst Rev. 2014(8):CD000053.
   Web of Science ®Google Scholar
• Del Villar LP, Burguillo FJ, López-Abán J, et al. Systematic review and meta-analysis of artemisinin based therapies for the treatment and prevention of schistosomiasis. PLoS ONE. 2012;7:e45867.
   PubMed Web of Science ®Google Scholar
• Activity of Mefloquine Against Urinary Schistosomiasis. [ cited 2019Nov13]. Available from: https://clinicaltrials.gov/ct2/show/NCT01132248?cond=schistosomiasis&draw=2&rank=8
   Google Scholar
• Anti-Schistosomiasis Vaccine: Sm14 Phase 2b-Sn in School Children. [ cited 2019Nov13]. Available from: https://clinicaltrials.gov/ct2/show/NCT03799510?cond=Schistosomiasis&draw=2&rank=5
   Google Scholar
• Pottie K, Mayhew AD, Morton RL, et al. Prevention and assessment of infectious diseases among children and adult migrants arriving to the European Union/European Economic Association: a protocol for a suite of systematic reviews for public health and health systems. BMJ Open. 2017;7(9):e014608.
   PubMed Web of Science ®Google Scholar
• Rath B, Swenshon S, Haase K, et al. Using a mobile application to detect health needs among children and adolescents who are newly arrived migrants in Europe. J Public Health (Oxf). 2018. DOI:10.1093/pubmed/fdy191.
   Google Scholar
• Souliotis K, Saridi M, Banou K, et al. Health and health needs of migrants in detention in Greece: shedding light to an unknown reality. Global Health. 2019;15(1):4.
   PubMedGoogle Scholar